Fig. 1
Flowchart illustrating the process of patient selection from four medical centers in this study. ALK, anaplastic lymphoma kinase; PFS, progression-free survival
Fig. 1 | Cancer Imaging
Flowchart illustrating the process of patient selection from four medical centers in this study. ALK, anaplastic lymphoma kinase; PFS, progression-free survival